Articles with public access mandates - Diane F JelinekLearn more
Not available anywhere: 3
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study
P Baliakas, A Hadzidimitriou, LA Sutton, E Minga, A Agathangelidis, ...
The lancet haematology 1 (2), e74-e84, 2014
Mandates: US National Institutes of Health, Swedish Research Council, Government of Italy
Monitoring M-proteins in patients with multiple myeloma using heavy-chain variable region clonotypic peptides and LC–MS/MS
DR Barnidge, RC Tschumper, JD Theis, MR Snyder, DF Jelinek, ...
Journal of proteome research 13 (4), 1905-1910, 2014
Mandates: US National Institutes of Health
Chronic lymphocytic leukemia with mutated IGHV4-34 receptors: shared and distinct immunogenetic features and clinical outcomes
A Xochelli, P Baliakas, I Kavakiotis, A Agathangelidis, LA Sutton, E Minga, ...
Clinical Cancer Research 23 (17), 5292-5301, 2017
Mandates: Swedish Research Council, European Commission, Government of Italy
Available somewhere: 79
Ibrutinib–rituximab or chemoimmunotherapy for chronic lymphocytic leukemia
TD Shanafelt, XV Wang, NE Kay, CA Hanson, S O’Brien, J Barrientos, ...
New England Journal of Medicine 381 (5), 432-443, 2019
Mandates: US National Institutes of Health
Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study
A Dispenzieri, JA Katzmann, RA Kyle, DR Larson, LJ Melton, CL Colby, ...
The Lancet 375 (9727), 1721-1728, 2010
Mandates: US National Institutes of Health
Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia
TD Shanafelt, TG Call, CS Zent, B LaPlant, DA Bowen, M Roos, ...
Journal of Clinical Oncology 27 (23), 3808-3814, 2009
Mandates: US National Institutes of Health
LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis
A Gutierrez Jr, RC Tschumper, X Wu, TD Shanafelt, J Eckel-Passow, ...
Blood, The Journal of the American Society of Hematology 116 (16), 2975-2983, 2010
Mandates: US National Institutes of Health
Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia
TD Shanafelt, TG Call, CS Zent, JF Leis, B LaPlant, DA Bowen, M Roos, ...
Cancer 119 (2), 363-370, 2013
Mandates: US National Institutes of Health
Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia
TD Shanafelt, NE Kay, KG Rabe, TG Call, CS Zent, K Maddocks, ...
Journal of Clinical Oncology 27 (24), 3959-3963, 2009
Mandates: US National Institutes of Health
Platelet-derived growth factor (PDGF)–PDGF receptor interaction activates bone marrow–derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications …
W Ding, TR Knox, RC Tschumper, W Wu, SM Schwager, JC Boysen, ...
Blood, The Journal of the American Society of Hematology 116 (16), 2984-2993, 2010
Mandates: US National Institutes of Health
BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma
C Correia, PA Schneider, H Dai, A Dogan, MJ Maurer, AK Church, ...
Blood, The Journal of the American Society of Hematology 125 (4), 658-667, 2015
Mandates: US National Institutes of Health
Bone marrow stromal cells protect lymphoma B‐cells from rituximab‐induced apoptosis and targeting integrin α‐4‐β‐1 (VLA‐4) with natalizumab can overcome this resistance
M Mraz, CS Zent, AK Church, DF Jelinek, X Wu, S Pospisilova, SM Ansell, ...
British journal of haematology 155 (1), 53-64, 2011
Mandates: US National Institutes of Health
Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia
TD Shanafelt, KG Rabe, NE Kay, CS Zent, DF Jelinek, MS Reinalda, ...
Cancer 116 (20), 4777-4787, 2010
Mandates: US National Institutes of Health
Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial
TD Shanafelt, XV Wang, CA Hanson, EM Paietta, S O’Brien, J Barrientos, ...
Blood, The Journal of the American Society of Hematology 140 (2), 112-120, 2022
Mandates: US National Institutes of Health
Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia
R Claus, DM Lucas, S Stilgenbauer, AS Ruppert, L Yu, M Zucknick, ...
Journal of Clinical Oncology 30 (20), 2483-2491, 2012
Mandates: US National Institutes of Health
B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome
TD Shanafelt, NE Kay, G Jenkins, TG Call, CS Zent, DF Jelinek, ...
Blood, The Journal of the American Society of Hematology 113 (18), 4188-4196, 2009
Mandates: US National Institutes of Health
The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma
CS Zent, W Ding, SM Schwager, MS Reinalda, JD Hoyer, DF Jelinek, ...
British journal of haematology 141 (5), 615-621, 2008
Mandates: US National Institutes of Health
Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL
A Vardi, A Dagklis, L Scarfo, D Jelinek, D Newton, F Bennett, J Almeida, ...
Blood, The Journal of the American Society of Hematology 121 (22), 4521-4528, 2013
Mandates: Fondazione Cariplo
Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes
SA Parikh, JF Leis, KG Chaffee, TG Call, CA Hanson, W Ding, ...
Cancer 121 (17), 2883-2891, 2015
Mandates: US National Institutes of Health
Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early–intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and …
CS Zent, CR Secreto, BR LaPlant, ND Bone, TG Call, TD Shanafelt, ...
Leukemia research 32 (12), 1849-1856, 2008
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program